bisoprolol has been researched along with Arrhythmias, Cardiac in 17 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisoprolol has anti-arrhythmic effects, but its direct effect on I(Na) in cardiac cells remains unclear." | 5.34 | Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure. ( Deng, CY; Kuang, SJ; Tang, HF; Wu, SL; Zhang, WC, 2007) |
| "The authors describe two cases of takotsubo cardiomyopathy developing after an abrupt withdrawal of carvedilol and bisoprolol." | 3.79 | [Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome]. ( Arabadzisz, H; Jávor, K; Sármán, B; Tomcsányi, J; Wagner, V; Zsoldos, A, 2013) |
| "Carvedilol is one of the most effective beta blockers for preventing ventricular tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic benefits remain unclear." | 3.77 | Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. ( Back, TG; Chen, H; Chen, J; Chen, SR; Chen, W; Cheng, H; Duff, HJ; Feldman, AM; Fill, M; Gillis, AM; Guo, A; Jiang, D; Jones, PP; Li, X; Smith, CD; Song, LS; Tian, X; Vembaiyan, K; Wang, A; Wang, R; Xiao, J; Xie, C; Yang, D; Zhang, J; Zhang, L; Zhong, X; Zhou, Q; Zhu, W, 2011) |
| "Baroreflex sensitivity was assessed in 287 patients with history of myocardial infarction and left ventricular ejection fraction < or =40% by phenylephrine test and was found to be depressed (4." | 3.72 | [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction]. ( Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG, 2004) |
| "The heart failure is one of the pathologies with major social and economic impact in the western world." | 2.44 | [Chronic heart failure and sudden death: the message of CIBIS-III]. ( Dequarti, MC; Poggio, L; Vanoli, E, 2007) |
| "Strikingly, arrhythmia events were more frequently detected in BrS-hiPSC-CMs." | 1.72 | A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. ( Akin, I; Albers, S; Cyganek, L; Diecke, S; Dinkel, H; Duru, F; El-Battrawy, I; Hohn, A; Huang, M; Janssen, JWG; Kleinsorge, M; Lan, H; Lang, S; Li, X; Li, Y; Liao, Z; Maywald, L; Müller, J; Qiao, L; Rose, L; Saguner, A; Schimanski, T; Swamy, N; Xi, Y; Xu, Q; Yang, Z; Zhang, F; Zhao, Z; Zhong, R; Zhou, X, 2022) |
| "Within the COPD GOLD II stage group, there appears to be no statistically significant difference in the number of exacerbations between the patients taking verapamil and digoxin (n = 24) and the patients taking BBs alone (n = 15), although, in patients taking BBs alone, there appears to be a trend towards a decrease in the exacerbations compared to the number of exacerbations in patients taking verapamil and digoxin (p = 0." | 1.51 | Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease. ( Bedak, O; Begic, E; Bradaric, H; Custovic, F; Durak-Nalbantic, A; Hodzic, E; Mujakovic, A; Prnjavorac, B; Zvizdic, F, 2019) |
| "Bisoprolol has anti-arrhythmic effects, but its direct effect on I(Na) in cardiac cells remains unclear." | 1.34 | Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure. ( Deng, CY; Kuang, SJ; Tang, HF; Wu, SL; Zhang, WC, 2007) |
| "Bisoprolol have been confirmed to have strictly beta-blocking properties." | 1.27 | Electrophysiological effects of bisoprolol. ( Feruglio, GA; Gradnik, R; Proclemer, A; Savonitto, S, 1987) |
| "Bisoprolol was about 2 times more effective in suppressing isoprenaline-induced increases in LVdP/dtmax than those in heart rate." | 1.27 | Bisoprolol improves perfusion of ischaemic myocardium in anaesthetized pigs. ( den Boer, MO; Rensen, RJ; Sassen, LM; Saxena, PR; Verdouw, PD, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, R | 1 |
| Schimanski, T | 1 |
| Zhang, F | 1 |
| Lan, H | 1 |
| Hohn, A | 1 |
| Xu, Q | 1 |
| Huang, M | 1 |
| Liao, Z | 1 |
| Qiao, L | 1 |
| Yang, Z | 1 |
| Li, Y | 1 |
| Zhao, Z | 1 |
| Li, X | 2 |
| Rose, L | 1 |
| Albers, S | 1 |
| Maywald, L | 1 |
| Müller, J | 1 |
| Dinkel, H | 1 |
| Saguner, A | 1 |
| Janssen, JWG | 1 |
| Swamy, N | 1 |
| Xi, Y | 1 |
| Lang, S | 1 |
| Kleinsorge, M | 1 |
| Duru, F | 1 |
| Zhou, X | 1 |
| Diecke, S | 1 |
| Cyganek, L | 1 |
| Akin, I | 1 |
| El-Battrawy, I | 1 |
| Zvizdic, F | 1 |
| Begic, E | 1 |
| Mujakovic, A | 1 |
| Hodzic, E | 1 |
| Prnjavorac, B | 1 |
| Bedak, O | 1 |
| Custovic, F | 1 |
| Bradaric, H | 1 |
| Durak-Nalbantic, A | 1 |
| Higa, A | 1 |
| Hoshi, H | 1 |
| Yanagisawa, Y | 1 |
| Ito, E | 1 |
| Morisawa, G | 1 |
| Imai, JI | 1 |
| Watanabe, S | 1 |
| Takagi, M | 1 |
| Prajapati, C | 1 |
| Ojala, M | 1 |
| Aalto-Setälä, K | 1 |
| Swissa, M | 1 |
| Shimoni, S | 1 |
| Talotta, R | 1 |
| Atzeni, F | 1 |
| Batticciotto, A | 1 |
| Ventura, D | 1 |
| Sarzi-Puttini, P | 1 |
| Fazio, G | 1 |
| Sarulo, F | 1 |
| Licata, P | 1 |
| D'Angelo, L | 1 |
| Passantino, S | 1 |
| Visconti, C | 1 |
| Zarcone, P | 1 |
| Spanò, C | 1 |
| Novo, G | 1 |
| Novo, S | 1 |
| Zhou, Q | 1 |
| Xiao, J | 1 |
| Jiang, D | 1 |
| Wang, R | 1 |
| Vembaiyan, K | 1 |
| Wang, A | 1 |
| Smith, CD | 1 |
| Xie, C | 1 |
| Chen, W | 1 |
| Zhang, J | 1 |
| Tian, X | 1 |
| Jones, PP | 1 |
| Zhong, X | 1 |
| Guo, A | 1 |
| Chen, H | 1 |
| Zhang, L | 1 |
| Zhu, W | 1 |
| Yang, D | 1 |
| Chen, J | 1 |
| Gillis, AM | 1 |
| Duff, HJ | 1 |
| Cheng, H | 1 |
| Feldman, AM | 1 |
| Song, LS | 1 |
| Fill, M | 1 |
| Back, TG | 1 |
| Chen, SR | 1 |
| Tomcsányi, J | 1 |
| Jávor, K | 1 |
| Arabadzisz, H | 1 |
| Zsoldos, A | 1 |
| Wagner, V | 1 |
| Sármán, B | 1 |
| Kanopskiĭ, SG | 1 |
| Staritskiĭ, AG | 1 |
| Bozhko, AA | 1 |
| Tang, HF | 1 |
| Wu, SL | 1 |
| Deng, CY | 1 |
| Zhang, WC | 1 |
| Kuang, SJ | 1 |
| Dequarti, MC | 1 |
| Poggio, L | 1 |
| Vanoli, E | 1 |
| Biondi, B | 1 |
| Fazio, S | 1 |
| Carella, C | 1 |
| Sabatini, D | 1 |
| Amato, G | 1 |
| Cittadini, A | 1 |
| Bellastella, A | 1 |
| Lombardi, G | 1 |
| Saccà, L | 1 |
| Houle, MS | 1 |
| Altschuld, RA | 1 |
| Billman, GE | 1 |
| Ogawa, T | 1 |
| Hieda, N | 1 |
| Sugiyama, S | 1 |
| Ito, T | 1 |
| Satake, T | 1 |
| Ozawa, T | 1 |
| Proclemer, A | 1 |
| Gradnik, R | 1 |
| Savonitto, S | 1 |
| Feruglio, GA | 1 |
| Sassen, LM | 1 |
| den Boer, MO | 1 |
| Rensen, RJ | 1 |
| Saxena, PR | 1 |
| Verdouw, PD | 1 |
1 review available for bisoprolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
[Chronic heart failure and sudden death: the message of CIBIS-III].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents | 2007 |
16 other studies available for bisoprolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Topics: Action Potentials; Arrhythmias, Cardiac; Bisoprolol; Brugada Syndrome; Calcium Channels, L-Type; Hum | 2022 |
Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Case-Control | 2019 |
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Ce | 2017 |
Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
Topics: Action Potentials; Arrhythmias, Cardiac; Bisoprolol; Cardiomyopathy, Hypertrophic; Epinephrine; Hear | 2018 |
Cardiac Tumor Lysis-Induced Ventricular Arrhythmia?
Topics: Adult; Anti-Arrhythmia Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; | 2017 |
Possible relationship between certolizumab pegol and arrhythmias: report of two cases.
Topics: Aged; Antirheumatic Agents; Arrhythmias, Cardiac; Arthritis, Rheumatoid; Bisoprolol; Certolizumab Pe | 2016 |
Ivabradine versus bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; | 2010 |
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Calcium; Calci | 2011 |
[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting En | 2013 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2004 |
Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Aorta, Abdominal; Aortic Coarctation; Arrhythmias, Cardiac; Bisopro | 2007 |
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.
Topics: Adult; Arrhythmias, Cardiac; Bisoprolol; Echocardiography; Electrocardiography; Female; Heart Rate; | 1994 |
Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2001 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coron | 1989 |
Electrophysiological effects of bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Atrioventricular Node; Bisoprolol; Bundle o | 1987 |
Bisoprolol improves perfusion of ischaemic myocardium in anaesthetized pigs.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Hemod | 1988 |